Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Ferriere
Michael Ferriere
Novartis
Ophthalmology
Medicine
Macular degeneration
Anatomy
VEGF receptors
3
Papers
5
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
LLF580, an FGF21 Analog, Reduces Triglycerides and Hepatic Fat in obese adults with modest hypertriglyceridemia.
2021
The Journal of Clinical Endocrinology and Metabolism
Daniel J. Rader
Eleftheria Maratos-Flier
Amanda Nguyen
Doug Hom
Michael Ferriere
Yifang Li
Jill Kompa
Miljen Martic
Markus Hinder
Craig T. Basson
David Yowe
John L. Diener
Allison B. Goldfine
Cllf X study team
Show All
Source
Cite
Save
Citations (1)
Topical ocular TRPV1 antagonist SAF312 was well tolerated and effectively reduced pain after photorefractive keratectomy (PRK)
2021
Investigative Ophthalmology & Visual Science
Kalliopi Stasi
Vance Thompson
Majid Moshirfar
Thomas E. Clinch
Stephen V. Scoper
Steven H. Linn
Avery McIntosh
Yifang Li
Matt Eaton
Michela Montecchi Palmer
Sameena Haque
Michael Ferriere
Show All
Source
Cite
Save
Citations (0)
Topical VEGF receptor inhibitor, LHA510, did not demonstrate efficacy in a Proof-of-Concept study in patients with neovascular age-related macular degeneration (nv AMD)
2018
Investigative Ophthalmology & Visual Science
Stephen Poor
Christopher M. Adams
Michael Ferriere
Andreas Weichselberger
Cynthia L. Grosskreutz
Georges Weissgerber
Show All
Source
Cite
Save
Citations (4)
1